Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxc1
|
ENSMUSG00000050295.2 | forkhead box C1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_31802548_31802827 | Foxc1 | 3946 | 0.197841 | -0.57 | 1.9e-06 | Click! |
chr13_31814307_31814974 | Foxc1 | 8007 | 0.170967 | -0.49 | 8.1e-05 | Click! |
chr13_31812545_31814223 | Foxc1 | 6751 | 0.175710 | -0.39 | 1.8e-03 | Click! |
chr13_31809526_31810053 | Foxc1 | 3156 | 0.221560 | -0.35 | 6.7e-03 | Click! |
chr13_31803163_31804425 | Foxc1 | 2839 | 0.231586 | -0.34 | 7.0e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_115817324_115818606 | 17.27 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr15_103250315_103251530 | 16.04 |
Nfe2 |
nuclear factor, erythroid derived 2 |
543 |
0.62 |
chr1_132366786_132367836 | 12.70 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
239 |
0.89 |
chr9_44340460_44342952 | 12.21 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr5_64810297_64813272 | 11.34 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr8_94986231_94987228 | 10.33 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
1161 |
0.36 |
chr14_69282071_69282727 | 10.10 |
Gm20236 |
predicted gene, 20236 |
259 |
0.8 |
chr14_69500320_69500976 | 10.09 |
Gm37094 |
predicted gene, 37094 |
258 |
0.81 |
chr2_84735706_84738103 | 9.90 |
Ypel4 |
yippee like 4 |
2677 |
0.11 |
chr12_4872599_4872933 | 9.38 |
Mfsd2b |
major facilitator superfamily domain containing 2B |
1579 |
0.27 |
chr10_75939108_75939976 | 9.08 |
Gm867 |
predicted gene 867 |
1069 |
0.25 |
chr4_115057577_115059724 | 8.73 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
839 |
0.56 |
chr16_92824962_92826063 | 8.38 |
Runx1 |
runt related transcription factor 1 |
266 |
0.94 |
chr8_67948178_67948899 | 8.37 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
3341 |
0.28 |
chr12_78863892_78864556 | 8.34 |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
2094 |
0.25 |
chr17_79352010_79352240 | 8.22 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
882 |
0.6 |
chr11_83065104_83067047 | 8.18 |
Slfn2 |
schlafen 2 |
963 |
0.31 |
chr17_36871480_36871911 | 8.15 |
Trim10 |
tripartite motif-containing 10 |
2121 |
0.14 |
chr19_7018033_7019009 | 8.09 |
Fermt3 |
fermitin family member 3 |
824 |
0.38 |
chr1_135132701_135133163 | 7.89 |
Ptpn7 |
protein tyrosine phosphatase, non-receptor type 7 |
207 |
0.62 |
chr11_70228540_70230880 | 7.75 |
Bcl6b |
B cell CLL/lymphoma 6, member B |
29 |
0.93 |
chr13_20185326_20185824 | 7.71 |
Elmo1 |
engulfment and cell motility 1 |
368 |
0.92 |
chr19_45445658_45446098 | 7.71 |
Btrc |
beta-transducin repeat containing protein |
370 |
0.86 |
chr11_117798237_117798922 | 7.64 |
6030468B19Rik |
RIKEN cDNA 6030468B19 gene |
919 |
0.33 |
chr8_84701273_84703379 | 7.62 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr2_181241290_181242534 | 7.56 |
Helz2 |
helicase with zinc finger 2, transcriptional coactivator |
51 |
0.95 |
chr14_69281512_69281946 | 7.54 |
Gm20236 |
predicted gene, 20236 |
411 |
0.68 |
chr2_127369985_127371247 | 7.51 |
Adra2b |
adrenergic receptor, alpha 2b |
7330 |
0.15 |
chr8_104963800_104964181 | 7.42 |
Ces2g |
carboxylesterase 2G |
2215 |
0.17 |
chr8_84703616_84705950 | 7.41 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr19_32238551_32238899 | 7.40 |
Sgms1 |
sphingomyelin synthase 1 |
87 |
0.98 |
chr13_75709278_75709841 | 7.36 |
Ell2 |
elongation factor RNA polymerase II 2 |
1848 |
0.23 |
chr9_111055888_111057545 | 7.33 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
530 |
0.62 |
chr10_75697240_75697855 | 7.21 |
Cabin1 |
calcineurin binding protein 1 |
2828 |
0.19 |
chr19_53194082_53195694 | 7.10 |
Add3 |
adducin 3 (gamma) |
65 |
0.97 |
chr4_40850011_40850208 | 7.06 |
Mir5123 |
microRNA 5123 |
29 |
0.53 |
chr4_135727528_135728972 | 7.04 |
Il22ra1 |
interleukin 22 receptor, alpha 1 |
78 |
0.96 |
chr19_46623097_46624579 | 7.02 |
Wbp1l |
WW domain binding protein 1 like |
437 |
0.77 |
chr6_58642449_58642948 | 7.00 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
2116 |
0.36 |
chr17_48300015_48301474 | 6.96 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr2_24386288_24387076 | 6.94 |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
65 |
0.97 |
chr3_100486792_100487398 | 6.92 |
Tent5c |
terminal nucleotidyltransferase 5C |
2099 |
0.23 |
chr14_66999338_66999780 | 6.91 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
98 |
0.96 |
chr7_105762080_105763247 | 6.91 |
Gm15645 |
predicted gene 15645 |
342 |
0.76 |
chr17_29493756_29495031 | 6.85 |
Pim1 |
proviral integration site 1 |
986 |
0.37 |
chr19_12573120_12574715 | 6.79 |
Fam111a |
family with sequence similarity 111, member A |
394 |
0.72 |
chr15_12193885_12195324 | 6.77 |
Gm49240 |
predicted gene, 49240 |
2015 |
0.19 |
chr12_110975345_110976350 | 6.74 |
Ankrd9 |
ankyrin repeat domain 9 |
2408 |
0.19 |
chrX_48146526_48147857 | 6.63 |
Sash3 |
SAM and SH3 domain containing 3 |
755 |
0.65 |
chr7_103824785_103825302 | 6.59 |
Hbb-bs |
hemoglobin, beta adult s chain |
2682 |
0.09 |
chr17_56794746_56794916 | 6.59 |
Rfx2 |
regulatory factor X, 2 (influences HLA class II expression) |
11127 |
0.11 |
chr8_84741754_84745977 | 6.45 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
20858 |
0.09 |
chr1_132364605_132364812 | 6.40 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
240 |
0.89 |
chr4_40850257_40850410 | 6.39 |
Gm25931 |
predicted gene, 25931 |
69 |
0.44 |
chr19_55938446_55939225 | 6.32 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
40526 |
0.17 |
chr17_40812809_40813139 | 6.21 |
Rhag |
Rhesus blood group-associated A glycoprotein |
1790 |
0.29 |
chr13_97066853_97067365 | 6.17 |
Fam169a |
family with sequence similarity 169, member A |
177 |
0.94 |
chr11_87756102_87757558 | 6.15 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr4_116992571_116994399 | 6.14 |
Urod |
uroporphyrinogen decarboxylase |
112 |
0.92 |
chr4_62515031_62515361 | 6.13 |
Alad |
aminolevulinate, delta-, dehydratase |
4685 |
0.12 |
chr9_22135178_22135368 | 6.13 |
Acp5 |
acid phosphatase 5, tartrate resistant |
418 |
0.64 |
chr8_23035959_23037041 | 6.11 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr4_40852424_40852797 | 6.10 |
B4galt1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
1395 |
0.24 |
chr18_62176067_62177775 | 6.10 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr17_25961783_25962611 | 6.05 |
Capn15 |
calpain 15 |
1563 |
0.17 |
chr4_62516521_62517025 | 6.03 |
Alad |
aminolevulinate, delta-, dehydratase |
3108 |
0.15 |
chr19_7294483_7295524 | 6.03 |
Mark2 |
MAP/microtubule affinity regulating kinase 2 |
444 |
0.7 |
chr14_61683887_61685176 | 6.02 |
Gm37820 |
predicted gene, 37820 |
1021 |
0.34 |
chr3_57425771_57426240 | 6.01 |
Tm4sf4 |
transmembrane 4 superfamily member 4 |
691 |
0.74 |
chr2_36198146_36199404 | 6.01 |
Gm13429 |
predicted gene 13429 |
3539 |
0.16 |
chr4_134869303_134870057 | 6.01 |
Rhd |
Rh blood group, D antigen |
5144 |
0.18 |
chr14_55061871_55064122 | 6.00 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr7_3666562_3667626 | 5.99 |
Tmc4 |
transmembrane channel-like gene family 4 |
211 |
0.74 |
chr7_4629257_4630354 | 5.94 |
Tmem86b |
transmembrane protein 86B |
382 |
0.66 |
chr16_23058440_23059079 | 5.91 |
Kng1 |
kininogen 1 |
366 |
0.69 |
chr5_139381758_139382299 | 5.89 |
Gpr146 |
G protein-coupled receptor 146 |
1447 |
0.27 |
chr18_54422355_54422833 | 5.87 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
299 |
0.93 |
chr2_109281814_109282372 | 5.87 |
Kif18a |
kinesin family member 18A |
1224 |
0.4 |
chr14_69499762_69500195 | 5.84 |
Gm37094 |
predicted gene, 37094 |
412 |
0.69 |
chr2_32078207_32079756 | 5.84 |
Fam78a |
family with sequence similarity 78, member A |
371 |
0.77 |
chr17_31208121_31208604 | 5.83 |
Ubash3a |
ubiquitin associated and SH3 domain containing, A |
271 |
0.86 |
chr7_75612178_75613652 | 5.76 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr9_77434500_77435087 | 5.72 |
Lrrc1 |
leucine rich repeat containing 1 |
7402 |
0.2 |
chr1_74295387_74296968 | 5.70 |
Tmbim1 |
transmembrane BAX inhibitor motif containing 1 |
482 |
0.41 |
chr12_91744157_91744724 | 5.64 |
Ston2 |
stonin 2 |
585 |
0.74 |
chr18_61952844_61953759 | 5.63 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
217 |
0.94 |
chr5_137291350_137291708 | 5.62 |
Mir8116 |
microRNA 8116 |
2251 |
0.11 |
chr7_133700418_133700603 | 5.61 |
Uros |
uroporphyrinogen III synthase |
2028 |
0.21 |
chr6_41700162_41700414 | 5.57 |
Kel |
Kell blood group |
1120 |
0.37 |
chr18_44554845_44555098 | 5.54 |
Mcc |
mutated in colorectal cancers |
35455 |
0.2 |
chr4_152447653_152448768 | 5.48 |
Kcnab2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
531 |
0.76 |
chr7_109636154_109636606 | 5.46 |
Denn2b |
DENN domain containing 2B |
19233 |
0.15 |
chr8_105300988_105301570 | 5.42 |
E2f4 |
E2F transcription factor 4 |
2646 |
0.08 |
chr8_60952376_60953209 | 5.39 |
Clcn3 |
chloride channel, voltage-sensitive 3 |
1956 |
0.29 |
chr8_60981765_60981966 | 5.37 |
Clcn3 |
chloride channel, voltage-sensitive 3 |
1374 |
0.3 |
chr7_132773129_132773862 | 5.35 |
Fam53b |
family with sequence similarity 53, member B |
3421 |
0.25 |
chr7_142576289_142578620 | 5.34 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr10_80570596_80572042 | 5.33 |
Klf16 |
Kruppel-like factor 16 |
6002 |
0.08 |
chr1_58970537_58971332 | 5.33 |
Trak2 |
trafficking protein, kinesin binding 2 |
2495 |
0.2 |
chr14_41006333_41006867 | 5.32 |
Prxl2a |
peroxiredoxin like 2A |
320 |
0.88 |
chr6_116350657_116351316 | 5.30 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
53 |
0.96 |
chr6_86666221_86666938 | 5.29 |
Gm44292 |
predicted gene, 44292 |
1028 |
0.35 |
chr11_102308792_102311562 | 5.25 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
269 |
0.84 |
chr4_41388141_41388689 | 5.25 |
Kif24 |
kinesin family member 24 |
16371 |
0.12 |
chrX_42152749_42153623 | 5.25 |
Stag2 |
stromal antigen 2 |
1006 |
0.51 |
chr11_120628644_120631479 | 5.24 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
87 |
0.89 |
chr15_9078875_9079572 | 5.22 |
Nadk2 |
NAD kinase 2, mitochondrial |
3946 |
0.26 |
chr11_108395377_108395720 | 5.22 |
Apoh |
apolipoprotein H |
255 |
0.91 |
chr11_98911144_98911574 | 5.21 |
Cdc6 |
cell division cycle 6 |
3208 |
0.14 |
chr15_83169389_83169735 | 5.19 |
Cyb5r3 |
cytochrome b5 reductase 3 |
615 |
0.56 |
chr11_60934916_60936338 | 5.18 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
3561 |
0.16 |
chr15_83432069_83433241 | 5.17 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
160 |
0.94 |
chr18_56924289_56925465 | 5.15 |
Marchf3 |
membrane associated ring-CH-type finger 3 |
638 |
0.73 |
chr4_109405488_109405928 | 5.14 |
Ttc39aos1 |
Ttc39a opposite strand RNA 1 |
447 |
0.66 |
chr16_36934847_36935880 | 5.14 |
Hcls1 |
hematopoietic cell specific Lyn substrate 1 |
380 |
0.77 |
chr17_71267820_71268552 | 5.14 |
Emilin2 |
elastin microfibril interfacer 2 |
411 |
0.81 |
chr17_48449646_48450503 | 5.13 |
Tspo2 |
translocator protein 2 |
1 |
0.96 |
chr4_140860663_140860947 | 5.13 |
4930515B02Rik |
RIKEN cDNA 4930515B02 gene |
11888 |
0.12 |
chr13_45546862_45547471 | 5.12 |
Gmpr |
guanosine monophosphate reductase |
1013 |
0.64 |
chr4_87805839_87806716 | 5.12 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
17 |
0.99 |
chr4_63171690_63172135 | 5.12 |
Kif12 |
kinesin family member 12 |
121 |
0.96 |
chr3_89136417_89137539 | 5.10 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr1_120267677_120268469 | 5.10 |
Steap3 |
STEAP family member 3 |
2350 |
0.36 |
chr9_48340395_48340829 | 5.08 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
222 |
0.94 |
chr5_123131617_123134965 | 5.08 |
Rhof |
ras homolog family member F (in filopodia) |
599 |
0.36 |
chr5_88724073_88724993 | 5.07 |
Mob1b |
MOB kinase activator 1B |
3556 |
0.19 |
chr15_78571734_78572724 | 5.07 |
Rac2 |
Rac family small GTPase 2 |
552 |
0.62 |
chr16_38374654_38375717 | 5.06 |
Popdc2 |
popeye domain containing 2 |
3187 |
0.17 |
chr11_90726819_90728183 | 5.06 |
Tom1l1 |
target of myb1-like 1 (chicken) |
39135 |
0.15 |
chr18_10532033_10532184 | 5.03 |
Gm24894 |
predicted gene, 24894 |
19298 |
0.15 |
chr13_23744307_23745018 | 4.98 |
H3c3 |
H3 clustered histone 3 |
940 |
0.18 |
chr15_89322584_89323784 | 4.98 |
Adm2 |
adrenomedullin 2 |
464 |
0.63 |
chr8_122546551_122549259 | 4.97 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr8_13061441_13062199 | 4.95 |
Proz |
protein Z, vitamin K-dependent plasma glycoprotein |
855 |
0.41 |
chr7_127137544_127138135 | 4.93 |
Spn |
sialophorin |
16 |
0.94 |
chr1_136960004_136960405 | 4.90 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
176 |
0.96 |
chr8_80868770_80869328 | 4.89 |
Gm31105 |
predicted gene, 31105 |
10891 |
0.18 |
chr12_76674678_76675311 | 4.89 |
Sptb |
spectrin beta, erythrocytic |
35029 |
0.15 |
chr3_134199883_134200837 | 4.88 |
Gm30648 |
predicted gene, 30648 |
274 |
0.88 |
chr2_28617734_28617929 | 4.88 |
Gfi1b |
growth factor independent 1B |
2426 |
0.17 |
chr14_55605603_55606168 | 4.85 |
Irf9 |
interferon regulatory factor 9 |
65 |
0.9 |
chr14_32169655_32170013 | 4.83 |
Ncoa4 |
nuclear receptor coactivator 4 |
911 |
0.42 |
chr11_109614897_109615494 | 4.82 |
Gm11685 |
predicted gene 11685 |
1125 |
0.43 |
chr8_80867565_80868184 | 4.82 |
Gm31105 |
predicted gene, 31105 |
12066 |
0.18 |
chr4_130252226_130252946 | 4.80 |
Serinc2 |
serine incorporator 2 |
22632 |
0.13 |
chr16_58673183_58673392 | 4.79 |
Cpox |
coproporphyrinogen oxidase |
849 |
0.5 |
chr4_41272272_41273407 | 4.79 |
Ubap2 |
ubiquitin-associated protein 2 |
2277 |
0.18 |
chr19_24513378_24514001 | 4.78 |
Fam122a |
family with sequence similarity 122, member A |
36333 |
0.14 |
chr7_45238275_45239242 | 4.77 |
Cd37 |
CD37 antigen |
38 |
0.92 |
chr9_44515217_44515909 | 4.77 |
Cxcr5 |
chemokine (C-X-C motif) receptor 5 |
10858 |
0.07 |
chr13_38632397_38632933 | 4.76 |
Gm47400 |
predicted gene, 47400 |
2306 |
0.2 |
chr17_28007198_28009699 | 4.75 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
1103 |
0.37 |
chr11_97434598_97436859 | 4.75 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr8_77422621_77423309 | 4.72 |
Gm45407 |
predicted gene 45407 |
50449 |
0.12 |
chr10_89532535_89533889 | 4.72 |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
373 |
0.88 |
chr15_77754933_77755315 | 4.71 |
Apol8 |
apolipoprotein L 8 |
115 |
0.93 |
chr14_70707805_70707956 | 4.71 |
Xpo7 |
exportin 7 |
155 |
0.95 |
chr8_120368836_120369597 | 4.70 |
Gm22715 |
predicted gene, 22715 |
74333 |
0.08 |
chr5_74064229_74066220 | 4.67 |
Usp46 |
ubiquitin specific peptidase 46 |
524 |
0.65 |
chr2_84936571_84938205 | 4.66 |
Slc43a3 |
solute carrier family 43, member 3 |
498 |
0.71 |
chr2_25195300_25197035 | 4.65 |
Tor4a |
torsin family 4, member A |
592 |
0.43 |
chr12_13180713_13181236 | 4.65 |
Gm24208 |
predicted gene, 24208 |
17211 |
0.16 |
chr14_67000048_67000519 | 4.64 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
225 |
0.91 |
chr18_11053961_11055254 | 4.63 |
Gata6 |
GATA binding protein 6 |
431 |
0.83 |
chr12_78905977_78906329 | 4.63 |
Plek2 |
pleckstrin 2 |
811 |
0.62 |
chr2_79256898_79257323 | 4.63 |
Itga4 |
integrin alpha 4 |
1163 |
0.57 |
chr17_25086969_25087388 | 4.63 |
Ift140 |
intraflagellar transport 140 |
3493 |
0.13 |
chrX_103479028_103479792 | 4.60 |
Xist |
inactive X specific transcripts |
3844 |
0.1 |
chrX_53369327_53370791 | 4.60 |
Mospd1 |
motile sperm domain containing 1 |
443 |
0.82 |
chr7_90145807_90146092 | 4.59 |
Gm45222 |
predicted gene 45222 |
1 |
0.96 |
chr11_82845042_82846306 | 4.59 |
Rffl |
ring finger and FYVE like domain containing protein |
418 |
0.75 |
chr4_46400544_46400900 | 4.58 |
Hemgn |
hemogen |
3514 |
0.16 |
chr11_107454658_107455533 | 4.55 |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
15604 |
0.11 |
chr11_86586191_86587628 | 4.54 |
Vmp1 |
vacuole membrane protein 1 |
28 |
0.97 |
chr6_55338294_55340060 | 4.54 |
Aqp1 |
aquaporin 1 |
2745 |
0.22 |
chr15_6523323_6524085 | 4.53 |
Fyb |
FYN binding protein |
851 |
0.66 |
chr6_41702817_41703169 | 4.53 |
Kel |
Kell blood group |
1346 |
0.32 |
chr10_62664723_62665865 | 4.53 |
Gm18514 |
predicted gene, 18514 |
4509 |
0.13 |
chr6_136854322_136855143 | 4.53 |
Art4 |
ADP-ribosyltransferase 4 |
3001 |
0.12 |
chr18_54425271_54425660 | 4.52 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
3170 |
0.32 |
chrX_7966827_7967869 | 4.52 |
Gata1 |
GATA binding protein 1 |
562 |
0.55 |
chr9_107298004_107299417 | 4.47 |
Cish |
cytokine inducible SH2-containing protein |
445 |
0.63 |
chr1_88407096_88408235 | 4.46 |
Spp2 |
secreted phosphoprotein 2 |
259 |
0.91 |
chr5_114969022_114970855 | 4.45 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
18 |
0.91 |
chr11_83286099_83286599 | 4.43 |
Slfn14 |
schlafen 14 |
377 |
0.71 |
chr15_103253562_103255772 | 4.43 |
Nfe2 |
nuclear factor, erythroid derived 2 |
605 |
0.57 |
chr9_113970028_113970753 | 4.43 |
Gm47950 |
predicted gene, 47950 |
608 |
0.61 |
chr2_35060883_35061388 | 4.42 |
Hc |
hemolytic complement |
303 |
0.88 |
chr5_146250160_146250843 | 4.41 |
Gm15739 |
predicted gene 15739 |
1950 |
0.23 |
chr11_64931371_64931975 | 4.40 |
Elac2 |
elaC ribonuclease Z 2 |
47365 |
0.15 |
chr18_5603232_5604403 | 4.36 |
Zeb1 |
zinc finger E-box binding homeobox 1 |
73 |
0.96 |
chr15_31540525_31541003 | 4.36 |
Marchf6 |
membrane associated ring-CH-type finger 6 |
9711 |
0.13 |
chr10_95970803_95971600 | 4.34 |
Eea1 |
early endosome antigen 1 |
30444 |
0.15 |
chr8_70630745_70631808 | 4.34 |
Gdf15 |
growth differentiation factor 15 |
819 |
0.39 |
chr7_143007094_143009025 | 4.33 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr1_87620304_87621692 | 4.32 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
371 |
0.85 |
chr8_104962508_104963341 | 4.32 |
Ces2g |
carboxylesterase 2G |
1149 |
0.31 |
chr1_173332160_173333204 | 4.31 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
820 |
0.54 |
chr2_127362687_127364202 | 4.31 |
Adra2b |
adrenergic receptor, alpha 2b |
158 |
0.94 |
chr2_165882235_165884653 | 4.30 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
766 |
0.54 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
3.8 | 11.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.7 | 11.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.4 | 20.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
3.4 | 10.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
3.3 | 9.8 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
3.3 | 3.3 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
3.2 | 16.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
3.2 | 9.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.2 | 9.5 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
3.0 | 9.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.7 | 10.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.6 | 55.4 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.6 | 7.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.4 | 12.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.4 | 9.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.4 | 12.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.3 | 2.3 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.2 | 8.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.2 | 6.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.2 | 6.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.2 | 10.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.2 | 6.5 | GO:0008228 | opsonization(GO:0008228) |
2.1 | 6.4 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.1 | 19.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
2.1 | 6.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.1 | 6.2 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
2.1 | 8.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.1 | 6.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.1 | 6.2 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
2.0 | 6.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.0 | 6.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
2.0 | 6.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.0 | 6.0 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
2.0 | 2.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.9 | 1.9 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.9 | 5.7 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.9 | 9.3 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.9 | 9.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.8 | 7.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.8 | 9.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.8 | 5.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.7 | 21.0 | GO:0097286 | iron ion import(GO:0097286) |
1.7 | 5.2 | GO:0042117 | monocyte activation(GO:0042117) |
1.7 | 1.7 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.7 | 8.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.7 | 8.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.7 | 8.4 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.7 | 5.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.6 | 4.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.6 | 4.9 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.6 | 6.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.6 | 3.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.6 | 8.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.6 | 9.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.6 | 8.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.6 | 4.7 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.6 | 6.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.5 | 3.1 | GO:0051917 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
1.5 | 3.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
1.5 | 12.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.5 | 6.1 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.5 | 1.5 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
1.5 | 3.0 | GO:0015677 | copper ion import(GO:0015677) |
1.5 | 5.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.5 | 1.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.5 | 7.4 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
1.5 | 16.0 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.4 | 5.8 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.4 | 4.3 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.4 | 5.7 | GO:0032264 | IMP salvage(GO:0032264) |
1.4 | 4.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.4 | 4.2 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.4 | 1.4 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
1.4 | 1.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.4 | 4.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.4 | 2.7 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.4 | 4.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
1.4 | 4.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.4 | 6.8 | GO:0070836 | caveola assembly(GO:0070836) |
1.3 | 4.0 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
1.3 | 9.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.3 | 1.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.3 | 4.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.3 | 4.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.3 | 5.3 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.3 | 6.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.3 | 3.9 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.3 | 5.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.3 | 5.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.3 | 5.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.3 | 5.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.3 | 1.3 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.3 | 6.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.3 | 6.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.3 | 3.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.3 | 8.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.3 | 3.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.3 | 5.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.3 | 25.0 | GO:0048821 | erythrocyte development(GO:0048821) |
1.2 | 3.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
1.2 | 5.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.2 | 5.0 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.2 | 3.7 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.2 | 2.5 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
1.2 | 9.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.2 | 3.6 | GO:0002432 | granuloma formation(GO:0002432) |
1.2 | 12.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.2 | 2.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.2 | 4.8 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.2 | 1.2 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
1.2 | 3.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.2 | 5.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.2 | 1.2 | GO:0050904 | diapedesis(GO:0050904) |
1.2 | 2.4 | GO:0002254 | kinin cascade(GO:0002254) |
1.2 | 4.7 | GO:0009597 | detection of virus(GO:0009597) |
1.2 | 3.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.2 | 7.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.2 | 15.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.2 | 5.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.2 | 3.5 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.1 | 8.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.1 | 3.4 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.1 | 3.4 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.1 | 4.6 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
1.1 | 3.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.1 | 10.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.1 | 7.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.1 | 5.7 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.1 | 3.4 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.1 | 2.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.1 | 3.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.1 | 2.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.1 | 2.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.1 | 6.7 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.1 | 3.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.1 | 3.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.1 | 1.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.1 | 3.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.1 | 1.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 2.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.1 | 2.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.1 | 3.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.1 | 2.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.1 | 4.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.1 | 4.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.1 | 7.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.1 | 4.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.1 | 3.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.1 | 3.2 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.1 | 19.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.1 | 11.8 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
1.1 | 3.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 6.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
1.0 | 2.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.0 | 7.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.0 | 2.1 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.0 | 1.0 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
1.0 | 3.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.0 | 3.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.0 | 6.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.0 | 1.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.0 | 2.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.0 | 2.0 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.0 | 4.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.0 | 4.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.0 | 8.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.0 | 2.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.0 | 4.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.0 | 8.9 | GO:0045730 | respiratory burst(GO:0045730) |
1.0 | 2.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.0 | 4.9 | GO:0046618 | drug export(GO:0046618) |
1.0 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.0 | 2.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.0 | 1.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.0 | 1.0 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
1.0 | 2.0 | GO:0051665 | membrane raft localization(GO:0051665) |
1.0 | 1.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.0 | 12.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.0 | 2.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.0 | 16.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.0 | 3.8 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
1.0 | 1.0 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.9 | 5.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.9 | 4.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.9 | 2.8 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.9 | 2.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.9 | 25.4 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.9 | 6.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.9 | 2.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.9 | 2.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.9 | 2.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.9 | 3.7 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.9 | 1.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.9 | 4.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.9 | 3.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.9 | 2.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.9 | 1.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.9 | 15.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.9 | 2.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.9 | 5.4 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.9 | 0.9 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.9 | 6.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.9 | 2.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.9 | 2.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.9 | 0.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.9 | 1.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.9 | 4.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.9 | 1.7 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.9 | 6.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.9 | 7.8 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.9 | 1.7 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.9 | 0.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.9 | 2.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.9 | 6.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.9 | 1.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.9 | 5.2 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.9 | 1.7 | GO:0033092 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.9 | 2.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.8 | 1.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.8 | 0.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.8 | 2.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.8 | 2.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.8 | 1.7 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.8 | 10.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.8 | 2.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.8 | 2.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 | 0.8 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.8 | 4.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 2.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.8 | 1.6 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.8 | 0.8 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.8 | 0.8 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.8 | 1.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.8 | 1.6 | GO:0001555 | oocyte growth(GO:0001555) |
0.8 | 3.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.8 | 1.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.8 | 0.8 | GO:1901656 | glycoside transport(GO:1901656) |
0.8 | 2.4 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.8 | 3.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.8 | 1.6 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.8 | 2.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 1.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.8 | 11.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.8 | 6.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.8 | 3.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.8 | 2.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 2.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 2.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.8 | 4.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.8 | 1.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.8 | 3.9 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.8 | 3.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.8 | 2.3 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.8 | 7.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.8 | 4.6 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
0.8 | 2.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.8 | 2.3 | GO:0006188 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.8 | 0.8 | GO:1902403 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.8 | 2.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.8 | 0.8 | GO:0042116 | macrophage activation(GO:0042116) |
0.8 | 3.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.8 | 3.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.8 | 1.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.8 | 2.3 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.7 | 3.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.7 | 1.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.7 | 13.4 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
0.7 | 2.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.7 | 0.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.7 | 0.7 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.7 | 2.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.7 | 1.5 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.7 | 5.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 2.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.7 | 0.7 | GO:0003166 | bundle of His development(GO:0003166) |
0.7 | 0.7 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.7 | 0.7 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.7 | 2.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.7 | 0.7 | GO:0006848 | pyruvate transport(GO:0006848) |
0.7 | 3.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.7 | 3.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.7 | 1.4 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.7 | 2.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.7 | 5.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.7 | 2.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.7 | 2.8 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.7 | 0.7 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.7 | 4.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.7 | 2.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 1.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.7 | 6.4 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.7 | 2.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 3.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.7 | 1.4 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.7 | 2.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.7 | 1.4 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.7 | 2.8 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.7 | 18.7 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.7 | 0.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.7 | 2.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.7 | 2.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 2.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.7 | 2.7 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.7 | 1.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.7 | 1.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.7 | 3.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.7 | 0.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.7 | 2.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.7 | 1.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.7 | 3.4 | GO:0015879 | carnitine transport(GO:0015879) |
0.7 | 2.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 0.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.7 | 0.7 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.7 | 0.7 | GO:0045472 | response to ether(GO:0045472) |
0.7 | 0.7 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.7 | 1.3 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.7 | 8.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.7 | 2.6 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.7 | 2.0 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 3.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.7 | 2.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.7 | 3.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 3.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.7 | 1.3 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.7 | 2.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.6 | 8.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.6 | 7.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 0.6 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.6 | 1.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 1.9 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 6.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.6 | 5.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.6 | 1.9 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.6 | 3.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.6 | 7.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.6 | 1.9 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.6 | 7.0 | GO:0010226 | response to lithium ion(GO:0010226) |
0.6 | 1.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.6 | 1.3 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.6 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.6 | 1.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 1.9 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.6 | 1.9 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.6 | 1.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 2.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.6 | 1.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.6 | 9.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.6 | 1.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 3.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.6 | 7.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 1.8 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.6 | 4.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 1.8 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.6 | 0.6 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.6 | 1.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.6 | 4.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.6 | 3.6 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.6 | 2.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.6 | 8.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.6 | 3.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.6 | 1.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.6 | 1.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.6 | 1.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.6 | 1.8 | GO:0061010 | gall bladder development(GO:0061010) |
0.6 | 4.7 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.6 | 0.6 | GO:0032252 | secretory granule localization(GO:0032252) |
0.6 | 2.9 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.6 | 1.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.6 | 2.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.6 | 2.9 | GO:0018904 | ether metabolic process(GO:0018904) |
0.6 | 2.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 1.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.6 | 1.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.6 | 13.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.6 | 1.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.6 | 3.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 4.0 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.6 | 8.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.6 | 2.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.6 | 0.6 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.6 | 0.6 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.6 | 4.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 1.7 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.6 | 9.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.6 | 3.4 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.6 | 3.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 1.7 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.6 | 1.7 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.6 | 1.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 2.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 4.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.6 | 7.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.6 | 2.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 2.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.6 | 1.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.6 | 1.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.6 | 1.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 2.2 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.6 | 12.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 1.7 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.6 | 3.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.6 | 2.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.6 | 1.1 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.6 | 0.6 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.6 | 0.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.5 | 2.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 2.7 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.5 | 1.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 0.5 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.5 | 0.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.5 | 6.5 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.5 | 4.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.5 | 11.8 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.5 | 1.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.5 | 1.6 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.5 | 2.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 3.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 1.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 1.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.5 | 5.3 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.5 | 3.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 1.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.5 | 3.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.5 | 4.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.5 | 0.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 0.5 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 5.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.5 | 2.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.5 | 1.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.5 | 0.5 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.5 | 0.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.5 | 3.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.5 | 1.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 4.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.5 | 0.5 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 3.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 1.5 | GO:0035483 | gastric emptying(GO:0035483) |
0.5 | 3.6 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.5 | 1.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.5 | 1.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 1.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 1.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 2.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.5 | 1.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.5 | 1.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 3.0 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.5 | 4.5 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.5 | 0.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.5 | 0.5 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.5 | 2.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 4.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.5 | 2.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.5 | 3.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.5 | 1.0 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.5 | 1.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.5 | 2.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.5 | 2.9 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.5 | 2.0 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.5 | 1.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.5 | 2.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 5.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.5 | 0.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.5 | 4.9 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.5 | 0.5 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.5 | 0.5 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.5 | 0.5 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.5 | 1.9 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.5 | 1.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 2.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 0.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.5 | 1.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.5 | 1.0 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.5 | 19.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.5 | 0.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.5 | 0.5 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.5 | 1.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.5 | 1.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.5 | 1.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 2.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 5.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.5 | 1.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 0.5 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.5 | 1.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 1.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 1.4 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.5 | 4.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.5 | 14.2 | GO:0006414 | translational elongation(GO:0006414) |
0.5 | 0.9 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.5 | 0.9 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.5 | 1.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.5 | 3.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.5 | 4.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 0.5 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.5 | 1.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.5 | 1.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 | 1.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.5 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 1.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 2.3 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.5 | 0.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.5 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 0.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 0.5 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.5 | 1.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.5 | 2.3 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.5 | 2.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 0.9 | GO:0000237 | leptotene(GO:0000237) |
0.5 | 12.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.5 | 4.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 1.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.5 | 0.5 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.4 | 4.5 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.4 | 0.9 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 2.7 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.4 | 3.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 0.9 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 2.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 1.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.4 | 1.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 0.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 1.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 0.4 | GO:0061724 | lipophagy(GO:0061724) |
0.4 | 0.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 4.0 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.4 | 0.9 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.4 | 0.4 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.4 | 0.4 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.4 | 5.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 14.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.4 | 0.9 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 3.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.4 | 0.9 | GO:0051593 | response to folic acid(GO:0051593) |
0.4 | 2.1 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.4 | 5.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 1.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 0.9 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.4 | 0.9 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.4 | 0.9 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.4 | 1.7 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 0.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.4 | 0.4 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.4 | 1.7 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.4 | 1.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 3.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 2.5 | GO:0031167 | rRNA methylation(GO:0031167) |
0.4 | 1.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 1.7 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 2.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.4 | 2.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.4 | 0.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.4 | 0.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 1.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 2.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.4 | 0.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.4 | 2.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 0.4 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.4 | 15.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 0.8 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.4 | 0.8 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.4 | 3.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.4 | 0.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 1.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.4 | 1.2 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.4 | 0.8 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 2.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 5.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 2.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.4 | 1.2 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.4 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 0.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 1.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 2.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 3.6 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.4 | 5.2 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 10.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 2.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 5.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 1.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 0.4 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.4 | 0.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.4 | 4.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 2.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 1.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.4 | 1.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.4 | 2.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 1.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 4.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 2.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 1.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 3.5 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.4 | 3.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 2.0 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.4 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 2.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 0.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.4 | 0.8 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 1.9 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.4 | 0.4 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.4 | 1.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 3.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 1.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 0.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.4 | 0.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.4 | 0.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 3.4 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.4 | 7.7 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.4 | 3.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 3.8 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.4 | 1.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.4 | 1.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.4 | 0.4 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.4 | 0.4 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.4 | 0.8 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.4 | 1.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.4 | 3.8 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 0.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.4 | 0.8 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.4 | 2.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 0.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 2.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 3.0 | GO:0007343 | egg activation(GO:0007343) |
0.4 | 6.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 1.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 1.1 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 5.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.4 | 0.7 | GO:0032782 | bile acid secretion(GO:0032782) |
0.4 | 0.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.4 | 5.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 1.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.4 | 0.4 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.4 | 0.4 | GO:0034204 | lipid translocation(GO:0034204) |
0.4 | 2.9 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.4 | 1.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.4 | 0.7 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.4 | 1.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 2.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.4 | 2.9 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.4 | 0.7 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.4 | 1.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 0.7 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.4 | 1.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 2.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.4 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 0.4 | GO:0060416 | response to growth hormone(GO:0060416) |
0.4 | 2.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.4 | 1.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.4 | 0.7 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.4 | 1.8 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.4 | 0.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 1.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 1.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 0.7 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 2.8 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 0.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 2.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 3.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.3 | 1.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 5.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 1.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 1.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 2.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 0.3 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.3 | 1.7 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 7.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 1.4 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.3 | 8.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 5.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.3 | 1.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 1.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 1.4 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.3 | 1.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 3.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.3 | 2.4 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.3 | 1.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 1.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 1.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 1.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 1.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 0.7 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.3 | 11.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 1.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 5.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 1.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.3 | 1.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 0.3 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.3 | 1.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.3 | 1.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 1.0 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 0.7 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.3 | 6.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 1.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.3 | 1.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 1.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 8.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.3 | 2.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 1.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 1.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.3 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 1.9 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.9 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.3 | 1.6 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.3 | 3.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 1.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 2.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 1.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 2.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 0.3 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.3 | 0.6 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 1.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 1.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 2.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 0.9 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 0.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 3.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 7.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 2.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 2.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 3.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 1.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 0.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 0.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 2.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 0.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 0.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 0.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 1.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 0.6 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.3 | 1.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 2.1 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 1.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 2.4 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.3 | 0.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 0.6 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 0.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 0.9 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 0.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 0.6 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.3 | 12.4 | GO:0009060 | aerobic respiration(GO:0009060) |
0.3 | 1.2 | GO:0019081 | viral translation(GO:0019081) |
0.3 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 0.6 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 2.9 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 1.8 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.3 | 3.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 0.3 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.3 | 0.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 0.9 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.3 | 1.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.3 | 1.5 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 1.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.4 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.3 | 3.2 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.3 | 2.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.3 | 0.3 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.3 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 1.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 1.1 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.3 | 0.9 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 0.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.3 | 2.9 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 0.6 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.3 | 0.3 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.3 | 4.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 0.6 | GO:0061009 | common bile duct development(GO:0061009) |
0.3 | 0.6 | GO:0002839 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.3 | 2.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 2.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 3.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 0.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 1.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 2.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 0.8 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.3 | 0.3 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.3 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.3 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.3 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.3 | 0.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 1.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.3 | 1.9 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.3 | 0.8 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 1.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.3 | 1.4 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.3 | 10.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.3 | 0.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 1.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 0.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 2.7 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.3 | 3.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.3 | 0.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 1.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 1.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.3 | 0.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 0.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 2.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.3 | 0.5 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.3 | 1.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.3 | 2.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 1.6 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 0.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 1.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 16.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.3 | 3.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 1.6 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 0.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 0.5 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.3 | 0.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 0.8 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.3 | 1.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 0.5 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.3 | 0.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 0.3 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 0.5 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.3 | 1.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 1.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 0.8 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 1.0 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.3 | 4.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 1.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 1.3 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.3 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 0.2 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.2 | 2.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 1.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 3.4 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.2 | 1.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 2.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 1.4 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.2 | 0.5 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.2 | 5.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 0.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.5 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.2 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.2 | 0.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 0.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.2 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.2 | 1.4 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.2 | 1.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 1.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 1.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.2 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 0.5 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 1.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.2 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 8.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.2 | 0.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 0.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 1.8 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.7 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 1.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 2.4 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.2 | 6.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 1.6 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.2 | 1.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 2.6 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 0.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 1.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.4 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.2 | 2.8 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.9 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.2 | 1.1 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.2 | 0.4 | GO:0042420 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.2 | 0.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 3.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.2 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.2 | 0.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.2 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 2.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 7.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 0.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.2 | 0.4 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.2 | 1.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.2 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 0.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.2 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.2 | 0.8 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 1.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 2.7 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 0.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 1.0 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 1.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.8 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.2 | 0.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 5.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.2 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.2 | 2.6 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 3.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.2 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.2 | 1.4 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.2 | 1.6 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 1.0 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.2 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.2 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.2 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.6 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 1.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 1.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.6 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.2 | 12.5 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.9 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.2 | 0.4 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 0.4 | GO:0042255 | ribosome assembly(GO:0042255) |
0.2 | 0.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 1.3 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.2 | 0.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.7 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.2 | 3.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.2 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.2 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.4 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 2.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 2.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 2.5 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 2.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 1.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.0 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.2 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.2 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 4.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.8 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.8 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.2 | 1.8 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.2 | 0.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 6.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 2.0 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.5 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.2 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.8 | GO:0006547 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 1.9 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.2 | 0.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 1.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:0072239 | metanephric glomerulus vasculature development(GO:0072239) |
0.2 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 1.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 0.3 | GO:0043038 | amino acid activation(GO:0043038) |
0.2 | 0.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 0.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.2 | 0.6 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 1.0 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 0.2 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.2 | 3.6 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.5 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 1.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.5 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 1.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 7.5 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.2 | 0.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 1.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 3.8 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.2 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 0.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.5 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 1.0 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.9 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.9 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 1.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.7 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.3 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.1 | 0.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 1.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.4 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 1.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.3 | GO:1990748 | cellular detoxification(GO:1990748) |
0.1 | 0.6 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.4 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 1.4 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 2.0 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.1 | 0.1 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.4 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 0.6 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.1 | 0.3 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.4 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.5 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.3 | GO:0072528 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.1 | 3.0 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 1.3 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.3 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.3 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 14.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 1.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 2.2 | GO:0044264 | cellular polysaccharide metabolic process(GO:0044264) |
0.1 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.1 | 1.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.6 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 1.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.4 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.2 | GO:0090110 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.2 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.1 | 2.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 1.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 0.6 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.1 | GO:0045132 | meiotic chromosome segregation(GO:0045132) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.1 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.1 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.1 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 1.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 2.6 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.2 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 1.8 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.1 | GO:0009215 | purine deoxyribonucleotide metabolic process(GO:0009151) purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.1 | 0.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.2 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 4.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.9 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.9 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.1 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.4 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.1 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 15.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0019076 | viral release from host cell(GO:0019076) |
0.1 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.2 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.1 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.1 | 0.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 0.1 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.1 | 0.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.1 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.1 | 0.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.4 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.2 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 2.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) deoxyribonucleotide catabolic process(GO:0009264) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.5 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.1 | 8.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.1 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0009310 | amine catabolic process(GO:0009310) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 1.0 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0008050 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.1 | 0.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.6 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.3 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.2 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.6 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.2 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.3 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 2.8 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 2.5 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 1.1 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.1 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.1 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 1.4 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 1.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.6 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.3 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 2.0 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.1 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 4.5 | GO:0045087 | innate immune response(GO:0045087) |
0.1 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 6.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0072376 | protein activation cascade(GO:0072376) |
0.1 | 0.1 | GO:0002702 | positive regulation of production of molecular mediator of immune response(GO:0002702) |
0.1 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 1.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 1.6 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.8 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.2 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.9 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 1.0 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.3 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.0 | 1.1 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 1.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 1.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.4 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.5 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 1.7 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.3 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.0 | 0.3 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 0.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.0 | 0.0 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.0 | 0.0 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.0 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.0 | 0.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.0 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.0 | 0.0 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.0 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.5 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.0 | 1.2 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.0 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.0 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.0 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.3 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.0 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.0 | 0.3 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.0 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.0 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.0 | 0.0 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.0 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.0 | 0.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 15.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.1 | 18.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.1 | 6.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.1 | 12.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.0 | 6.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.8 | 5.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.8 | 9.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.5 | 4.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.5 | 4.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.5 | 10.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.5 | 6.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.5 | 2.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.5 | 1.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.4 | 4.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.3 | 1.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
1.3 | 3.9 | GO:0031523 | Myb complex(GO:0031523) |
1.2 | 3.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.2 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
1.2 | 5.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.2 | 15.1 | GO:0042581 | specific granule(GO:0042581) |
1.2 | 4.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.1 | 9.1 | GO:0001939 | female pronucleus(GO:0001939) |
1.1 | 9.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.0 | 6.3 | GO:0045180 | basal cortex(GO:0045180) |
1.0 | 3.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.0 | 8.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.0 | 5.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.0 | 4.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.0 | 4.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.0 | 4.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.0 | 10.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 3.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.0 | 2.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.0 | 4.9 | GO:0005579 | membrane attack complex(GO:0005579) |
1.0 | 3.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.0 | 9.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.0 | 2.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.0 | 3.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.9 | 3.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.9 | 2.7 | GO:1990462 | omegasome(GO:1990462) |
0.9 | 3.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.9 | 3.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.9 | 7.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.9 | 4.4 | GO:0005638 | lamin filament(GO:0005638) |
0.9 | 3.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.9 | 2.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.9 | 1.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.9 | 5.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.8 | 3.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.8 | 6.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.8 | 2.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.8 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.8 | 2.5 | GO:0043219 | lateral loop(GO:0043219) |
0.8 | 7.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.8 | 3.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 3.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.8 | 4.0 | GO:0000805 | X chromosome(GO:0000805) |
0.8 | 4.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.8 | 4.0 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.8 | 8.7 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.8 | 4.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.8 | 3.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.8 | 6.2 | GO:0042627 | chylomicron(GO:0042627) |
0.8 | 20.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 3.1 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.8 | 0.8 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 2.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.8 | 3.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 3.0 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 7.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 2.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.7 | 2.2 | GO:0005712 | chiasma(GO:0005712) |
0.7 | 1.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 2.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.7 | 2.1 | GO:0097413 | Lewy body(GO:0097413) |
0.7 | 3.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 6.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 2.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.7 | 2.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 3.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 0.7 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.7 | 28.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.7 | 2.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.7 | 4.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 2.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 10.0 | GO:0031430 | M band(GO:0031430) |
0.7 | 17.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.7 | 2.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 7.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 55.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.6 | 2.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 1.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 2.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.6 | 1.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.6 | 4.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 2.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 1.8 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.6 | 3.6 | GO:0005818 | aster(GO:0005818) |
0.6 | 3.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.6 | 3.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.6 | 1.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 1.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.6 | 2.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 0.6 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.6 | 1.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.6 | 38.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.6 | 2.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.5 | 4.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.5 | 2.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.5 | 8.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.5 | 3.2 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 4.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 4.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 2.1 | GO:0005776 | autophagosome(GO:0005776) |
0.5 | 5.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 7.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.5 | 1.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.5 | 1.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 5.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.5 | 1.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 0.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.5 | 1.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.5 | 1.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.5 | 2.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 5.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.5 | 3.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 1.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 2.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 3.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 4.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.5 | 3.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.5 | 2.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.5 | 2.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.5 | 2.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.5 | 2.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.5 | 1.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.5 | 2.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.5 | 1.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.5 | 2.8 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 1.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.5 | 20.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.5 | 11.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.5 | 0.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.5 | 18.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.5 | 0.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.5 | 6.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.5 | 39.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.5 | 12.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.5 | 3.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.5 | 11.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 8.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 5.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 4.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 0.4 | GO:0036452 | ESCRT complex(GO:0036452) |
0.4 | 2.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 8.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 4.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 2.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 1.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 6.8 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 1.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 1.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 23.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 9.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 1.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 2.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 7.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.4 | 2.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 1.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 1.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 7.3 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 3.2 | GO:0032797 | SMN complex(GO:0032797) |
0.4 | 1.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 1.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.4 | 1.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 1.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 6.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 1.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 24.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 15.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.4 | 6.9 | GO:1990391 | DNA repair complex(GO:1990391) |
0.4 | 22.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 4.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 1.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 0.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 2.6 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 8.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 3.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 3.0 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.4 | 2.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 1.1 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 16.4 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.4 | 1.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 2.9 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 2.5 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.4 | 4.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.4 | 1.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 4.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 2.5 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 3.6 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 1.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 7.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 0.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 3.8 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.3 | 3.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 2.4 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 1.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 5.3 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 8.9 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 0.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.3 | 4.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 1.0 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 4.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.3 | 0.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 0.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 11.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 1.0 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 3.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 0.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 11.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 0.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 11.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 5.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 4.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 6.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 1.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 2.4 | GO:0031672 | A band(GO:0031672) |
0.3 | 7.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 12.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 20.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 0.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 2.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 6.7 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.3 | 0.9 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.3 | 10.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 2.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.9 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.3 | 12.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 4.9 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.3 | 71.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.4 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 1.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 1.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 2.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.3 | 5.1 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 3.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.3 | 5.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 1.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 3.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.8 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 6.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 1.3 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 1.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 8.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 15.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 1.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 0.2 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 28.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.2 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 6.6 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.2 | 5.2 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.2 | 2.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 1.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 2.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 2.4 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 4.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 1.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 4.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 10.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 2.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 1.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 5.5 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 8.9 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 3.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 2.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 4.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.9 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 2.0 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 7.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 1.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 7.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 14.7 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 2.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 8.7 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 37.6 | GO:0005635 | nuclear envelope(GO:0005635) |
0.2 | 15.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 5.6 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 1.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 16.7 | GO:0005819 | spindle(GO:0005819) |
0.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 4.1 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 0.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 11.4 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.5 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.5 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.2 | 0.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 0.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 6.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 4.6 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.2 | 1.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 38.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 1.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 2.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 0.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 3.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 1.0 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.8 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 128.0 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 8.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 27.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 1.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.9 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 43.0 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 22.5 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 79.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 2.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.2 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 2.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 7.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 2.2 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 19.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.2 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 3.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.1 | GO:0044440 | endosomal part(GO:0044440) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 80.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 24.3 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.3 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 15.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.2 | 9.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.0 | 12.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.5 | 17.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.4 | 12.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
2.3 | 6.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.2 | 6.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.1 | 8.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.1 | 2.1 | GO:0019808 | polyamine binding(GO:0019808) |
2.1 | 6.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.9 | 13.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.9 | 5.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.9 | 7.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.8 | 11.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.8 | 9.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.8 | 5.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.8 | 5.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.8 | 5.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.7 | 5.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.7 | 6.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.6 | 6.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.6 | 6.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.6 | 8.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.6 | 4.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.6 | 4.7 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.6 | 6.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.5 | 6.2 | GO:0030911 | TPR domain binding(GO:0030911) |
1.5 | 4.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.5 | 4.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.5 | 4.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.5 | 7.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.5 | 8.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.5 | 7.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.4 | 13.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.4 | 14.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.4 | 4.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.4 | 4.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.4 | 6.9 | GO:0008199 | ferric iron binding(GO:0008199) |
1.4 | 2.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.3 | 5.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.3 | 3.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.3 | 3.8 | GO:0051425 | PTB domain binding(GO:0051425) |
1.3 | 5.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.2 | 3.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.2 | 3.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.2 | 2.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.2 | 3.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.2 | 17.8 | GO:0005521 | lamin binding(GO:0005521) |
1.2 | 4.7 | GO:0030984 | kininogen binding(GO:0030984) |
1.2 | 4.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.2 | 4.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.1 | 3.4 | GO:0035877 | death effector domain binding(GO:0035877) |
1.1 | 6.8 | GO:0043559 | insulin binding(GO:0043559) |
1.1 | 7.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.1 | 4.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.1 | 4.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.1 | 4.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.1 | 3.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.1 | 3.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.1 | 8.6 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.1 | 2.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.1 | 4.3 | GO:0034548 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
1.1 | 7.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.0 | 3.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
1.0 | 5.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.0 | 3.1 | GO:0004064 | arylesterase activity(GO:0004064) |
1.0 | 3.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.0 | 3.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.0 | 4.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 2.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.0 | 4.9 | GO:0005123 | death receptor binding(GO:0005123) |
1.0 | 2.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.0 | 4.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.0 | 1.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.0 | 5.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.0 | 2.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.0 | 2.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.9 | 1.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.9 | 7.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.9 | 5.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.9 | 2.7 | GO:1990188 | euchromatin binding(GO:1990188) |
0.9 | 2.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.9 | 2.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.9 | 2.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.9 | 7.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.9 | 2.7 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.9 | 0.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.9 | 3.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.9 | 2.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.9 | 2.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.9 | 15.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.9 | 6.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.9 | 4.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.9 | 0.9 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.9 | 4.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.9 | 6.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.9 | 3.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.9 | 16.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.8 | 4.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.8 | 12.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.8 | 5.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 5.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 7.4 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.8 | 2.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.8 | 3.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 4.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.8 | 3.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.8 | 0.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.8 | 5.6 | GO:0046790 | virion binding(GO:0046790) |
0.8 | 3.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.8 | 1.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.8 | 2.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.8 | 3.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.8 | 4.7 | GO:0005536 | glucose binding(GO:0005536) |
0.8 | 9.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.8 | 3.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 4.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.7 | 2.2 | GO:2001070 | starch binding(GO:2001070) |
0.7 | 2.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.7 | 3.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.7 | 3.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.7 | 3.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.7 | 2.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.7 | 5.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 6.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.7 | 2.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.7 | 2.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.7 | 1.5 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.7 | 5.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.7 | 2.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 2.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.7 | 2.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.7 | 4.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 0.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.7 | 4.9 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.7 | 6.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.7 | 2.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.7 | 2.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 4.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.7 | 11.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.7 | 2.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 1.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.7 | 5.5 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 0.7 | GO:0034618 | arginine binding(GO:0034618) |
0.7 | 2.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.7 | 0.7 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.7 | 1.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.7 | 4.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.7 | 0.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.7 | 2.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.7 | 2.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.7 | 3.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 4.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.6 | 3.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.6 | 2.6 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.6 | 3.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.6 | 2.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 2.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.6 | 3.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.6 | 5.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.6 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 3.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.6 | 3.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.6 | 2.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 5.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 1.2 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.6 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.6 | 2.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.6 | 1.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 1.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.6 | 17.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 21.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 4.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.6 | 1.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.6 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 3.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.6 | 0.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.6 | 4.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.6 | 3.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 3.0 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.6 | 6.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 2.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.6 | 1.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.6 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.6 | 2.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 3.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.6 | 5.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 1.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.6 | 1.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.6 | 1.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.6 | 29.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.6 | 2.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 0.6 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.6 | 2.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.6 | 1.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.6 | 1.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.6 | 1.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.6 | 1.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.6 | 2.2 | GO:0009374 | biotin binding(GO:0009374) |
0.6 | 1.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.6 | 6.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.5 | 2.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 4.4 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.5 | 2.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 2.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.5 | 2.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 15.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.5 | 3.8 | GO:0019825 | oxygen binding(GO:0019825) |
0.5 | 0.5 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.5 | 3.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 2.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 13.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 6.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 4.7 | GO:0001848 | complement binding(GO:0001848) |
0.5 | 2.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.5 | 1.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.5 | 2.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 1.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.5 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.5 | 1.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 1.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 2.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.5 | 7.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 1.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.5 | 26.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.5 | 3.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 1.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.5 | 2.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.5 | 3.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 1.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 2.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 2.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.5 | 19.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.5 | 4.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.5 | 1.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.5 | 5.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.5 | 0.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 2.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 2.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 10.2 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 6.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.5 | 1.0 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.5 | 6.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 1.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 4.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 1.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 1.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.5 | 0.9 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.5 | 1.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 2.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 0.9 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 4.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 3.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.5 | 1.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.5 | 8.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.5 | 0.9 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.5 | 1.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 1.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 3.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 4.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 1.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 3.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.5 | 1.8 | GO:0035473 | lipase binding(GO:0035473) |
0.5 | 1.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 1.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 8.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 1.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 1.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 1.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 2.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 1.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 2.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 1.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.4 | 2.6 | GO:0034809 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.4 | 1.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.4 | 1.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 0.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.4 | 3.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 6.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 1.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.4 | 2.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 9.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.4 | 1.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 0.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.4 | 1.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 0.9 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.4 | 3.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 2.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 1.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 2.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.4 | 2.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 1.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 2.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.4 | 7.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 4.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 1.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 5.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 5.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 5.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.4 | 13.1 | GO:0019209 | kinase activator activity(GO:0019209) |
0.4 | 0.8 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.4 | 1.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.4 | 1.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.4 | 2.0 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 1.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.4 | 1.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 2.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 1.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 0.8 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.4 | 2.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 15.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.4 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 2.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 2.4 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 32.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.4 | 8.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 1.6 | GO:0019864 | IgG binding(GO:0019864) |
0.4 | 1.2 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 3.5 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.4 | 2.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 1.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 15.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 1.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 6.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 10.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.4 | 2.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 1.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 3.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.4 | 4.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 1.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.4 | 2.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 2.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 1.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 0.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.4 | 5.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 1.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 2.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 2.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.4 | 1.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 2.9 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 2.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 2.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.4 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 2.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 2.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 5.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 9.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 4.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 2.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 2.4 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 1.7 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.3 | 1.7 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 11.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 1.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 9.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 1.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 2.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.0 | GO:0018597 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 3.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 2.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 2.0 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 1.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 4.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 3.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 6.6 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.3 | 13.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 2.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 6.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 50.2 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 1.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 17.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 11.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 38.8 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.3 | 0.3 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.3 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.3 | 15.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 0.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 4.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 2.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 21.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 0.9 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.3 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 0.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 2.8 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.3 | 0.9 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 0.9 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 2.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 0.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 5.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 5.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 2.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 0.6 | GO:0018660 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 2.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 6.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 1.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 6.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 1.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 0.6 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.3 | 0.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 1.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 3.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 8.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 4.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 2.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 3.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 3.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 1.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 1.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 1.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 1.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 2.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 11.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.3 | 2.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 0.9 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 1.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 1.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 12.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 0.9 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 0.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 2.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 2.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 0.9 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 3.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 7.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 0.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 13.9 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.3 | 2.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 5.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 8.3 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.3 | 2.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 2.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 3.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 6.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 1.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 8.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.3 | 1.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 1.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 7.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 1.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 2.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 14.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 2.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 2.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 1.2 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 1.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 39.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 1.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 1.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 2.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 6.4 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.2 | 1.2 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 8.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 10.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 1.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 1.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 0.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 7.1 | GO:0043906 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 4.1 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 1.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 2.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 3.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.7 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 1.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.2 | 6.7 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 1.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 5.0 | GO:0009055 | electron carrier activity(GO:0009055) |
0.2 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 15.7 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.2 | 0.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 7.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 0.6 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 1.7 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 2.3 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 3.4 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.2 | 1.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 1.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 6.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 4.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.0 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 5.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 19.6 | GO:0043773 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.2 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.4 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 1.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.6 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 2.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 2.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.2 | 1.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 4.1 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 6.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.2 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.2 | 13.2 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 14.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 2.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 1.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 3.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 4.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 4.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.1 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 3.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 3.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 4.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 1.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 5.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 1.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.5 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 1.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 1.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 0.9 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 0.5 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 0.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.5 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 1.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.7 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 5.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 2.4 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.1 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 6.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 3.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 2.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 6.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 11.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 5.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.4 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 1.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 2.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 59.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 1.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.9 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 1.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.0 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 1.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.1 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 4.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.4 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 15.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 8.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.2 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 0.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 4.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.1 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.1 | 2.2 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 2.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.9 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.1 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 1.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.7 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.5 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.5 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.4 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.0 | 0.1 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 1.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.9 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 2.2 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 18.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 15.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.4 | 19.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.3 | 37.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.2 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.1 | 48.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.1 | 7.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.1 | 10.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.1 | 1.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.0 | 21.1 | PID EPO PATHWAY | EPO signaling pathway |
1.0 | 39.6 | PID PLK1 PATHWAY | PLK1 signaling events |
1.0 | 27.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.9 | 2.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.9 | 9.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.8 | 21.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.8 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 6.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 19.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.7 | 5.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.7 | 17.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 7.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.7 | 2.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 6.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.6 | 16.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.6 | 1.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.6 | 39.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.6 | 3.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 8.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 0.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.6 | 11.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 10.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 23.6 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 3.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 6.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 1.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 20.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 7.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 14.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.5 | 42.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.5 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.5 | 3.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.5 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 13.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 13.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 1.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 4.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 3.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.4 | 6.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 10.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 6.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 12.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 5.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 3.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 4.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 5.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 1.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 2.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 5.6 | PID ATM PATHWAY | ATM pathway |
0.4 | 14.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 4.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 1.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 5.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 1.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 13.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 6.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 8.9 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 1.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 4.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 4.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 3.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 0.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 2.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 2.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 6.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 3.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 2.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 3.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 3.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 1.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 7.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 2.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 3.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 4.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 6.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 2.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 0.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 1.2 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 4.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 3.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 1.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 1.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 3.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 3.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 1.0 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 2.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 1.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 6.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 27.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 44.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.9 | 2.9 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.1 | 20.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.6 | 18.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.5 | 7.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.5 | 15.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.3 | 20.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.2 | 12.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.2 | 14.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.2 | 9.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.2 | 1.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.2 | 19.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.1 | 12.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
1.0 | 10.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.0 | 6.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.9 | 12.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.9 | 11.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.9 | 10.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.9 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.9 | 2.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.8 | 15.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.8 | 78.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.8 | 6.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.8 | 0.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.8 | 17.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.8 | 8.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 7.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.8 | 5.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.8 | 3.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.8 | 0.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.8 | 3.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.8 | 6.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.8 | 20.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.7 | 3.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.7 | 12.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 10.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.7 | 20.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.7 | 7.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 1.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.7 | 8.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.7 | 5.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 11.6 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.7 | 2.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.7 | 1.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 6.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.7 | 11.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 17.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.7 | 23.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.7 | 12.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 6.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.6 | 11.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 10.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 5.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.6 | 1.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 5.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 28.8 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.6 | 7.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.6 | 5.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.6 | 6.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 10.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 4.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 7.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 7.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 9.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.5 | 1.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.5 | 2.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 0.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.5 | 1.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 11.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 12.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 5.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.5 | 5.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 22.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.5 | 5.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 5.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.5 | 8.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 15.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.5 | 8.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 6.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 3.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 4.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 9.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 2.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 25.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 10.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 11.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.5 | 14.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.5 | 7.2 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.5 | 21.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 22.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.5 | 2.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 5.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.5 | 8.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 1.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 10.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 6.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.5 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 5.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 11.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 5.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 4.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 6.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 3.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 4.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 6.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 12.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 0.8 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.4 | 8.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 6.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 2.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 3.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.4 | 4.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 5.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 0.4 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.4 | 9.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 8.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 6.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.4 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 3.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 2.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 4.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.4 | 2.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 8.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 4.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 2.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 22.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 4.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 1.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 4.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 3.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 4.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 3.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 3.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 0.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 3.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 2.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 24.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 3.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 3.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.3 | 1.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 12.3 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.3 | 0.6 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 4.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.3 | 3.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 4.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 2.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 2.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 2.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 4.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 1.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 2.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 27.7 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.3 | 6.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 1.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 4.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 2.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 4.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 2.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 4.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 3.5 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.3 | 7.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 2.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 27.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 2.4 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.2 | 4.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 4.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 1.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 1.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 2.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 4.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 1.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 2.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 2.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 2.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 1.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 0.2 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.2 | 4.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 4.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 4.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 3.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 5.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 9.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 4.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 3.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 2.7 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.1 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 8.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 2.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.3 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 1.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.4 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |